Cathryn Julia Robbins

Title: Cathryn Julia Robbins: Innovator in Hematopoietic Treatments

Introduction

Cathryn Julia Robbins is a notable inventor based in Redwood City, CA (US). She has made significant contributions to the field of medical treatments, particularly in mitigating the side effects of chemotherapy and radiotherapy.

Latest Patents

Robbins holds a patent for her innovative work titled "Methods and treatments using toll-like receptor agonists to mitigate hematopoietic myeloid loss, increase gastrointestinal recovery and reduce tumor growth." This patent outlines methods for preventing side effects from chemotherapy and radiotherapy by administering a therapeutically effective amount of a toll-like receptor 2/6 (TLR 2/6) ligand, specifically fibroblast-stimulating lipopeptide 1 (FSL-1). The patent also includes methods for treating gastrointestinal disorders and increasing granulocyte colony-stimulating factor (G-CSF) production in subjects undergoing medical treatments.

Career Highlights

Robbins is affiliated with the University of North Carolina at Chapel Hill, where she continues her research and development in the medical field. Her work has the potential to significantly improve patient outcomes during cancer treatments.

Collaborations

Robbins has collaborated with esteemed colleagues such as Jenny P-y Ting and Willie June Brickey, contributing to advancements in her field through teamwork and shared expertise.

Conclusion

Cathryn Julia Robbins is a pioneering inventor whose work in hematopoietic treatments showcases her commitment to improving patient care. Her innovative approaches have the potential to change the landscape of cancer treatment and enhance the quality of life for many patients.